Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Inv. presentation
MYRIAD GENETICS INC (MYGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "SEPARATION AND CONSULTING AGREEMENT AND RELEASE OF CLAIMS"
08/04/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance&#59; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth"
07/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ASSET BASED LENDING",
"PLEDGE AND SECURITY AGREEMENT",
"Million Asset-Based Credit Facility SALT LAKE CITY, July 6, 2023"
06/02/2023 8-K Appointed a new director
06/02/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
03/27/2023 144 Form 144 - Report of proposed sale of securities:
03/02/2023 144 Form 144 - Report of proposed sale of securities:
03/01/2023 SC 13G Glenview Capital reports a 5.3% stake in Myriad Genetics, Inc.
03/01/2023 10-K Annual Report for the period ended December 31, 2022
02/28/2023 8-K Quarterly results
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 11.5% stake in Myriad Genetics Inc.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2023 SC 13G/A STATE STREET CORP reports a 6.2% stake in AMENDED FILING MYRIAD GENETICS INC
01/09/2023 SC 13G/A EARNEST PARTNERS LLC reports a 4.1% stake in MYRIAD GENETICS, INC.
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/01/2022 8-K Quarterly results
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "Myriad Genetics Reports Second Quarter Financial Results"
07/27/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT NO. 4"
06/29/2022 8-K Quarterly results
06/06/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/02/2022 8-K Quarterly results
05/12/2022 SC 13G Camber Capital Management LP reports a 5.8% stake in Myriad Genetics, Inc.
05/06/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/05/2022 8-K Quarterly results
04/14/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/01/2022 8-K Other Events  Interactive Data
02/25/2022 10-K Annual Report for the period ended December 31, 2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy